PIM (proviral integration site for Moloney murine leukaemia virus) kinases, comprising three highly homologous serine/threonine kinases, are involved in the pathogenesis and progression of multiple malignancies, including AML and are important effectors of FLT3‐ITD activity. The gene discussed is PIM1; the disease is acute myeloid leukemia.